✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Blueprint Medicines Corp

Common Name
Blueprint Medicines
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
682
Ticker
BPMC
Exchange
NASDAQ/NGS
Description
Blueprint Medicines Corp. is a biopharmaceutical company focused on developing targeted therapies to treat genomically defined cancers, rare diseases, and cancer immunotherapy. The company's primary p...

Disclosures of Blueprint Medicines

Explore Blueprint Medicines's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Blueprint Medicines's official channels and fully traceable to its official company sources.

The table below lists all of Blueprint Medicines's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

Fiscal Year / TypeLanguages
20242 disclosures
10-K
en
Financial & Extra-Financial Disclosure
20233 disclosures
Financial & Extra-Financial Disclosure
Sustainability Report
en
Annual Report
20222 disclosures
Corporate Responsibility Report (CRR)
en
10-K
20212 disclosures
10-K
Corporate Responsibility Report (CRR)
20201 disclosure
10-K
20191 disclosure
10-K
20181 disclosure
10-K
20171 disclosure
10-K
20161 disclosure
10-K
20151 disclosure
10-K
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?